Free Republic

FINDINGS Researchers reported three cases of severe liver problems yesterday, including one death, in patients at a North Carolina hospital after they began taking a novel antibiotic. The Food and Drug Administration said it was reviewing an unknown number of cases involving the drug, telithromycin, marketed as Ketek, and consulting with counterparts overseas. The FDA approved the drug in 2004. One patient at Carolinas Medical Center in Charlotte died after taking telithromycin. Another required and received a liver transplant, while the third recovered from drug-induced hepatitis after treatment with Ketek was stopped. --snip-- Oral Cancer Study False, Journal Says The...